SU579309A1 - Способ получени вакцины - Google Patents
Способ получени вакциныInfo
- Publication number
- SU579309A1 SU579309A1 SU7301967101A SU1967101A SU579309A1 SU 579309 A1 SU579309 A1 SU 579309A1 SU 7301967101 A SU7301967101 A SU 7301967101A SU 1967101 A SU1967101 A SU 1967101A SU 579309 A1 SU579309 A1 SU 579309A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- preparing vaccine
- vaccine
- preparing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/10011—Arenaviridae
- C12N2760/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU7301967101A SU579309A1 (ru) | 1973-11-16 | 1973-11-16 | Способ получени вакцины |
DE2452919A DE2452919C3 (de) | 1973-11-16 | 1974-11-07 | Verfahren zum Herstellen von inaktivierten Impfstoffen gegen Viruskrankheiten |
CS7739A CS172111B1 (ru) | 1973-11-16 | 1974-11-13 | |
GB4932374A GB1446107A (en) | 1973-11-16 | 1974-11-14 | Production of vaccines |
DD182362A DD114615A1 (ru) | 1973-11-16 | 1974-11-14 | |
SE7414326A SE418573B (sv) | 1973-11-16 | 1974-11-14 | Sett att framstella ett vaccin |
HU74LE762A HU175489B (hu) | 1973-11-16 | 1974-11-15 | Sposob poluchenija vakcin |
FR7438632A FR2251334B1 (ru) | 1973-11-16 | 1974-11-25 | |
US05/719,692 US4071619A (en) | 1973-11-16 | 1976-09-02 | Method of producing vaccines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU7301967101A SU579309A1 (ru) | 1973-11-16 | 1973-11-16 | Способ получени вакцины |
Publications (1)
Publication Number | Publication Date |
---|---|
SU579309A1 true SU579309A1 (ru) | 1977-11-05 |
Family
ID=20566763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU7301967101A SU579309A1 (ru) | 1973-11-16 | 1973-11-16 | Способ получени вакцины |
Country Status (9)
Country | Link |
---|---|
US (1) | US4071619A (ru) |
CS (1) | CS172111B1 (ru) |
DD (1) | DD114615A1 (ru) |
DE (1) | DE2452919C3 (ru) |
FR (1) | FR2251334B1 (ru) |
GB (1) | GB1446107A (ru) |
HU (1) | HU175489B (ru) |
SE (1) | SE418573B (ru) |
SU (1) | SU579309A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4328208A (en) * | 1981-05-20 | 1982-05-04 | Kurbanov Ildus A | Vaccine against chlamydous infections of farm animals |
US4880512A (en) * | 1984-02-16 | 1989-11-14 | Kollmorgen Corporation | Pulsed light selective photolysis process for treatment of biological media and products made thereby |
JPS60197629A (ja) * | 1984-03-16 | 1985-10-07 | Chemo Sero Therapeut Res Inst | HBs抗原の精製方法 |
JPS6176160A (ja) * | 1984-09-21 | 1986-04-18 | 松永 是 | 殺細胞方法 |
GB9018690D0 (en) * | 1990-08-24 | 1990-10-10 | Wellcome Found | Vaccines |
US5639461A (en) * | 1994-09-30 | 1997-06-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Influenza machine |
BR112012026095A2 (pt) | 2010-04-14 | 2015-09-15 | Emd Millipore Corp | métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos. |
-
1973
- 1973-11-16 SU SU7301967101A patent/SU579309A1/ru active
-
1974
- 1974-11-07 DE DE2452919A patent/DE2452919C3/de not_active Expired
- 1974-11-13 CS CS7739A patent/CS172111B1/cs unknown
- 1974-11-14 SE SE7414326A patent/SE418573B/xx unknown
- 1974-11-14 GB GB4932374A patent/GB1446107A/en not_active Expired
- 1974-11-14 DD DD182362A patent/DD114615A1/xx unknown
- 1974-11-15 HU HU74LE762A patent/HU175489B/hu unknown
- 1974-11-25 FR FR7438632A patent/FR2251334B1/fr not_active Expired
-
1976
- 1976-09-02 US US05/719,692 patent/US4071619A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2251334B1 (ru) | 1978-07-21 |
DE2452919A1 (de) | 1975-05-22 |
DD114615A1 (ru) | 1975-08-12 |
GB1446107A (en) | 1976-08-11 |
FR2251334A1 (ru) | 1975-06-13 |
DE2452919C3 (de) | 1981-01-22 |
SE418573B (sv) | 1981-06-15 |
US4071619A (en) | 1978-01-31 |
DE2452919B2 (de) | 1980-05-22 |
SE7414326L (ru) | 1975-05-20 |
HU175489B (hu) | 1980-08-28 |
CS172111B1 (ru) | 1976-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG23743A3 (en) | Method of preparing alpha-acylaldehydes | |
CA1033911A (en) | Method of preparing size | |
CA1028718A (en) | Method of preparing acrylic acid | |
CA982598A (en) | Method of preparing amidosilanes | |
CS183798B2 (en) | Method of preparing d-homosteroids | |
CA1012355A (en) | Method of preparing reducing gas | |
AU468003B2 (en) | Method of preparing medicinal compositions | |
SU579309A1 (ru) | Способ получени вакцины | |
SU584790A3 (ru) | Способ получени 7-ациламидо7-метоксицефалоспориновых соединений | |
BG24226A3 (en) | Method of preparing derivatives of 2-aminomethyl-4,6-dihalidephenol | |
CA1016952A (en) | Process of preparing p-benzoquinone | |
IL45870A (en) | Process for preparation of vaccines | |
CH611338A5 (en) | Process for the preparation of inactivated HB-Ag vaccines | |
CA1014971A (en) | Method of preparing n-(diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide | |
AU456857B2 (en) | Method of preparing stable dentifrice | |
CA1018546A (en) | Method of preparing p-chlorophenylenedlamine | |
CA1031376A (en) | Method of preparing 1-methyl-3-phenyl-indane | |
CS187407B2 (en) | Method of preparation of the anthelmintic means | |
CS182807B2 (en) | Method of preparing substituted 6-amidinopenicillanic acids | |
BG23744A3 (en) | Method of preparing 2-acylamino-benzylamines | |
CA988514A (en) | Method of preparing erythromycin compounds | |
BG23896A3 (en) | Method of preparing 2-amino-benzylamines | |
CA1015760A (en) | Preparation process for neopynaminol of cis-chrysanthemates | |
ZA741967B (en) | Method of preparing substituted 3-aminopro-l-enes | |
AU485928B2 (en) | Method of cold-joining parts |